Skip to main content
Caplight Logo









Esperto Medical

Esperto Medical

Private
Irvine, CaliforniaHealthcare & Life Scienceshttps://esperto.health

Last Round

Grant

Nov 6, 2026

Est. Valuation

$32M

Total Funding Raised

$15.25M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Esperto Medical operates in Healthcare & Life Sciences and is based in Irvine, California. Its latest recorded funding round was a Grant round in April 2026.

Esperto Medical is a health-diagnostics company that develops non-invasive, continuous blood pressure monitoring technology using acoustic resonance sensing.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Esperto Medical Comparables

Compare Esperto Medical with similar companies based on industry and business-model similarity.

Esperto Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dynocardia, Inc.
90%
CoraVie Medical
88%
Softsonics LLC
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Esperto Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 6, 2026
GrantApr 28, 2026
GrantJul 21, 2025
Series AFeb 18, 2025
Early FundingOct 26, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Alaina Brinley Rajagopal

Co-Founder, Chief Medical Officer

Founding Team

Aditya Rajagopal

CEO, Chairman, Co-Founder

Founding Team

Raymond Jimenez

Chief Technology Officer

Executive Team

Jeffrey Stoll

Chief Product Officer

Executive Team

For institutional investors. Book with your work email.

Esperto Medical Investors

Notable investors and investment history

Esperto Medical investors
InvestorRounds
Maverick VenturesSeries A
Wavemaker Three-Sixty HealthSeries A
Freeflow VenturesSeries A
Caltech Seed FundSeed
BOLD Capital PartnersSeries A
ARPA-HGrant
Rocket FundSeries A
Book a demo to see all 9 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 6, 2026

    Received grant funding to support operations.

  • Nov 6, 2026

    Developing Resonance Sonomanometry for cardiovascular monitoring in spaceflight.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • is_developingNov 6, 2026

    Esperto Medical, Inc.'s Resonance Sonomanometry(TM) technology is to be developed for continuous, calibration-free cardiovascular monitoring in terrestrial environments and spaceflight, with a TRISH grant supporting its adaptation for microgravity and extreme environments on Nov 6th '26.

Book a demo to see all news

For institutional investors. Book with your work email.

Esperto Medical Filings

Explore SEC and related filing metadata, where available.

Esperto Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Esperto Medical's valuation, stock price, and market status.

Is Esperto Medical a public or private company?

Esperto Medical is a private company.

What is the current stock price of Esperto Medical?

Esperto Medical is a private company, so its shares have no public market price. Caplight tracks Esperto Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Esperto Medical worth (valuation)?

Esperto Medical's valuation is estimated at $32.0M based on funding round data.

Can I buy Esperto Medical stock?

Esperto Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Esperto Medical's last funding round?

Esperto Medical's most recent funding round was Grant on November 6, 2026.

Who are the main investors in Esperto Medical?

Key investors in Esperto Medical include BOLD Capital Partners, Catalyst Health Ventures.

Will Esperto Medical IPO soon?

No public IPO plans have been announced for Esperto Medical.

How can I track Esperto Medical secondary market activity?

Caplight tracks bids, offers, and trades in Esperto Medical's shares on secondary markets.

Firmographic Details

HeadquartersIrvine, California
Employee Range14
Year Founded2018
Last FundingNov 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?